Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
8031 Cooper Creek Blvd., Unit 103
University Park, FL 34201
United States of America (the)
Phone
1-941-225-2515
Sector
Healthcare
Industry
Biotechnology
Employees
5
First IPO Date
April 23, 2026
| Name | Title | Pay | Year Born |
| Kelvin Cooper | CEO, SVP of Research & Development and Director | 190,417 | 1956 |
| Peter F. Ceccacci | CFO & VP of Administration | 160,000 | 1955 |
| Thomas Balzer | Chief Medical Officer & SVP of Clinical Development | 177,917 | 1960 |
| Tara Endress | Project Manager & Accounting Manager | 0 | N/A |
| Daniel Kontoh-Boateng | Investor Relations | 0 | N/A |
This biopharmaceutical company is dedicated to developing innovative antimicrobial therapies. Its array of anti-infective products is designed to tackle specific viral conditions, including avian influenza, Epstein-Barr Virus (EBV), and hepatitis B and C. Established by Roderic Dale on July 11, 2006, the firm maintains its principal office in Bradenton, Florida.